MedPath

Lidocaine Patch for Postoperative Analgesia After Laparoscopic Cholecystectomy

Phase 4
Conditions
Postoperative, Pain
Registration Number
NCT01485939
Lead Sponsor
Seoul National University Hospital
Brief Summary

The investigators hypothesized that application of a 5% lidocaine patch would be associated with reduced pain scores after operation compared with placebo patch in patients undergoing laparoscopic cholecystectomy.

Detailed Description

* The 5% lidocaine patch have been approved for the treatment of postherpetic neuralgia.

* The investigators hypothesized that application of a 5% lidocaine patch would be associated with reduced pain scores, pain controlled drug(opioids, NSAID) in post operative period.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • patients of ASA Ⅰ-Ⅱ
  • aged 18~65
  • scheduled to undergo elective laparoscopic cholecystectomy under general anesthesia.
Exclusion Criteria
  • patients with chronic pain
  • patients with taking regular analgesics
  • patients with allergy to ketorolac or lidocaine

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
post operative pain after laparoscopic cholecystectomypost operative periods

We will measure intensity of pain(numeric rating scale)at post operative 30 minutes, 1, 2, 4, 6, 12, 24, 48 hours.

Secondary Outcome Measures
NameTimeMethod
pain controlled drug doses in postoperative periods.postoperative periods

We will measure doses of pain controlled drug(opioid, NSAIDS) at post operative 30 minutes, 1, 2, 4, 6, 12, 24, 48 hours.

Trial Locations

Locations (1)

Seoul national university Bundang hospital

🇰🇷

Seongnam, Kyoung-ki-do, Korea, Republic of

Seoul national university Bundang hospital
🇰🇷Seongnam, Kyoung-ki-do, Korea, Republic of
Eunjoo Choi, MD
Contact
82-31-787-6572
ejchoi7956@gmail.com
Pyung Bok Lee, MD, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.